Anti-tumor necrosis factor alpha (anti-TNF-alpha) is used in the treatment of rheumatic diseases not responsive to first-line regimens. Data on the safety of anti-TNF-alpha in HIV-infected patients are scarce and conflicting. We describe a case of septic shock and multiorgan failure that occurred after etanercept initiation and influenza vaccination in an HIV-infected woman with rheumatoid arthritis.
Septic shock after seasonal influenza vaccination in an HIV-infected patient during treatment with etanercept for rheumatoid arthritis: a case report
Gentilotti, Elisa;
2013-01-01
Abstract
Anti-tumor necrosis factor alpha (anti-TNF-alpha) is used in the treatment of rheumatic diseases not responsive to first-line regimens. Data on the safety of anti-TNF-alpha in HIV-infected patients are scarce and conflicting. We describe a case of septic shock and multiorgan failure that occurred after etanercept initiation and influenza vaccination in an HIV-infected woman with rheumatoid arthritis.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
